Professor
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Dr. T. Peter Kingham obtained his undergraduate degree at Yale University and MD from SUNY Stony Brook. His general surgery residency was at New York University. He undertook a research fellowship in hepatic immunology in the DeMatteo Laboratory at Memorial Sloan Kettering. After finishing residency, he completed a two-year fellowship in surgical oncology at MSK prior to being appointed on the Hepatopancreatobiliary Service. He is Director of the Global Oncology Fellowship. Since 2015 he has been Director of Global Cancer Research and Training Program. In 2022 he was promoted to Professor. His primary research interests are determining how to improve cancer care for patients in low- and middle-income countries, building HPB surgery in low resource environments, and colorectal cancer liver metastasis management. Dr. Kingham is co-PI on multiple prospective studies in Nigeria, co-founded HPBridge within the IHPBA, and co-founded the African Research Group for Oncology (ARGO). He is PI of a UG3/UH3 and R01 NIH grants focused on colorectal cancer in Nigeria, a D43 NIH grant to build a cancer research training program in Nigeria, and a P20 grant to build an immuno-oncology center in Nigeria He has over 420 publications in peer-reviewed journals and authored 18 chapters.
Histotripsy is Hype for Liver Malignancies
Thursday, March 5, 2026
9:13 AM - 9:28 AM MST
Thursday, March 5, 2026
9:33 AM - 9:38 AM MST
Thursday, March 5, 2026
10:15 AM - 10:19 AM MST
Thursday, March 5, 2026
11:14 AM - 11:21 AM MST
P72. Rectum preservation in patients with synchronous metastasis of rectal cancer to the liver
Thursday, March 5, 2026
3:14 PM - 3:21 PM MST
BP11. Budget impact of implementing a financial navigation program for cancer patients in Nigeria
Friday, March 6, 2026
9:12 AM - 9:19 AM MST
PPS47. Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma
Friday, March 6, 2026
3:40 PM - 4:10 PM MST